Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Regulatory News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.941%)
Open: 69.00
High: 69.00
Low: 69.00
Prev. Close: 69.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Dealing Notification

18 Apr 2018 17:08

RNS Number : 3812L
NetScientific PLC
18 April 2018
 

18 April 2018

NetScientific plc

 

Directors Dealing Notification

 

NetScientific plc (AIM:NSCI) (the "Company"), the transatlantic healthcare IP commercialisation group, announces that on 17 April 2018 it received notification that Sir Richard Sykes, Barry Wilson, and Steve Smith (the "Directors"), subscribed for New Ordinary Shares (the "Shares") in the NetScientific Placing and Subscription (the "Placing") at a price of 52.5 pence per Share, with the Shares admitted to trading on AIM on 17 April 2018.

 

The details of the Directors' shareholdings in the Company following the Placing are as follows:

 

 

No. of Ordinary Shares as at 28 March 2018

(date of announcement of conditional Placing)

No. of New Ordinary Shares subscribed

No. of Ordinary Shares as at Admission

Percentage of enlarged share capital as at Admission

Sir Richard Sykes

62,500

30,952

93,452

0.12%

Barry Wilson

36,358

30,952

67,310

0.09%

Professor Stephen Smith

-

28,571

28,571

0.04%

 

The total number of voting rights in NetScientific is 78,561,866.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Sir Richard Sykes

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director - Chairman)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 30,952

 

d)

 

Aggregated information

 

Aggregated volume

 

 30,952

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Barry Wilson

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 30,952

 

d)

 

Aggregated information

 

Aggregated volume

 

 30,952

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Steve Smith

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 28,571

 

d)

 

Aggregated information

 

Aggregated volume

 

 28,571

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

For more information, please contact:

 

NetScientific plc

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

Tel: +44 (0)20 3514 1800

Consilium Strategic Communications

Mary-Jane Elliott/Jessica Hodgson

Chris Welsh/Laura Thornton

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

Stifel Nicolaus Europe Limited (NOMAD and Bookrunner)

Jonathan Senior/David Arch/Ben Maddison

 Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Placing Agent)

David Parsons/Christopher Britton/Bidhi Bhoma/Euan Brown

Tel: +44 (0)20 3709 5700

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUAUCUPRGQR
Date   Source Headline
3rd Apr 20184:09 pmRNSPosting of Circular
29th Mar 20187:00 amRNSProposed Placing and Subscription
29th Mar 20187:00 amRNSFull Year Results
19th Mar 20187:00 amRNSWanda Expanding to Orthopedic Analytics
13th Mar 20187:00 amRNSVortex Announces Partnership with BioView
15th Feb 20187:00 amRNSProAxsis Reports First NEATstik Sale
9th Feb 20187:00 amRNSVortex Releases Publication in Nature Scientific
16th Jan 20187:00 amRNSNetScientific Portfolio Update
8th Jan 20187:00 amRNSProAxsis Achieves CE Mark for Plasmin Immunoassay
4th Jan 20187:00 amRNSGlycotestT Completes Diagnostic Evaluation
12th Dec 20177:00 amRNSWanda Awarded Two Patents
21st Nov 20177:00 amRNSProAxsis: Sales Update
7th Nov 20177:00 amRNSVortex Announces First Commercial VTX-1 Sale
2nd Nov 20177:00 amRNSGlycotest Adds Allowed Chinese Patent to Portfolio
1st Nov 201711:00 amRNSVortex Announces Liquid Biopsy Study in NPJ
30th Oct 20177:00 amRNSProAxsis Showcases ProteaseTag® Research at NACFC
27th Oct 20177:00 amRNSProAxsis Partnership - US National Jewish Health
25th Oct 20177:00 amRNSDirectorate Change
5th Oct 20177:00 amRNSGlycotest Granted Japanese Patent
2nd Oct 20177:00 amRNSWanda Awarded US Patent
28th Sep 20177:00 amRNS2017 Interim Results
14th Sep 20177:00 amRNSProAxsis appoints Diagenics Limited as Distributor
11th Sep 20177:00 amRNSProAxsis Signs Partnership: Biotechnology Company
7th Sep 20177:00 amRNSNotice of Interim Results
4th Sep 20177:00 amRNSProAxsis is awarded a European CE Mark
24th Jul 20177:00 amRNSProAxsis awarded a Significant Innovate UK Grant
10th Jul 201712:00 pmRNSPDS Announces Clinical Collaboration with Merck
7th Jul 20177:00 amRNSGlycotest Strengthens Intellectual Property Reach
26th Jun 20177:00 amRNSGlycotest Update
21st Jun 201712:00 pmRNSResult of AGM
16th Jun 201710:05 amRNSHoldings in Company
15th Jun 20172:52 pmRNSHoldings in Company
12th Jun 201712:02 pmRNSResults of General Meeting
12th Jun 201711:10 amRNSResult of Placing
26th May 20173:52 pmRNSNotice of AGM and Annual Report & Accounts
26th May 201712:49 pmRNSResults of Placing and Subscription
25th May 201711:51 amRNSProposed Placing and Subscription
24th May 20177:00 amRNSVortex Initiates Clinical Research Studies
10th May 20177:00 amRNSProAxsis announces additional IP
5th May 20177:00 amRNSProAxsis Presents New Data at Major US Conference
24th Apr 20177:00 amRNSBTG purchases Wanda's shares in Oncoverse
3rd Apr 20177:00 amRNSFull Year Results for the year ended 31 Dec 2016
31st Mar 20177:00 amRNSVortex Biosciences Announces Publications
27th Mar 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSVortex Biosciences Launches VTX-1 Liquid Biopsy
15th Feb 20177:00 amRNSVortex Biosciences' CSO Wins SLAS Innovation Award
9th Feb 20177:00 amRNSVortex Biosciences' CSO Finalist for SLAS Award
30th Jan 20177:00 amRNSGrant of Options to Directors
20th Dec 20167:00 amRNSNew CEO appointed to Wanda
16th Dec 20167:00 amRNSExecuted Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.